3SBio Inc., of Shenyang, China, appointed Kevin Teo chief financial officer

Acadia Pharmaceuticals Inc., of San Diego, named John J. Kaiser vice president of strategic marketing and commercial development.

Affitech AS, of Oslo, Norway, appointed Sergej Kiprijanov vice president of discovery research and preclinical development.

Allos Therapeutics Inc., of Westminister, Colo., appointed Bruce K. Bennett vice president of manufacturing.

Alnylam Pharmaceuticals Inc., of Cambridge, Mass., appointed Edward Scolnick to its board of directors and scientific advisory board.

AlphaVax, of Research Triangle Park, N.C., appointed Mark Schleiss, David Bernstein, Robert Pass and Paul D. Griffiths to its cytomegalovirus advisory board and named Robert Olmsted as chairman.

Altea Therapeutics, of Atlanta, named Richard Guy to its scientific advisory board.